Medicinal Products

Dáil Éireann Debate, Tuesday - 1 October 2024

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Tuesday, 1 October 2024

Ceisteanna (439)

Gino Kenny

Ceist:

439. Deputy Gino Kenny asked the Minister for Health the reason the drug interferon alfa (pegasys) is in short supply and unavailable for those who are living with MPNs; if the drug besremi will be made available under the drug payments scheme (details supplied); and if he will make a statement on the matter. [38531/24]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile